44.16. Analysis.
Comparison 44 Adverse events within two years: etanercept vs. disease‐modifying anti‐rheumatic drug (DMARD), Outcome 16 Injection site haemorrhage.
Comparison 44 Adverse events within two years: etanercept vs. disease‐modifying anti‐rheumatic drug (DMARD), Outcome 16 Injection site haemorrhage.